NSC 172285 is primarily investigated for its potential applications in cancer research. It has been studied for its ability to inhibit specific cellular pathways that are crucial for the survival and proliferation of cancer cells. Researchers are exploring its use as a chemotherapeutic agent, particularly in targeting tumors that are resistant to conventional treatments. Additionally, NSC 172285 is being examined for its role in combination therapies, where it may enhance the efficacy of other anticancer drugs. Its mechanism of action involves interfering with key molecular processes, making it a promising candidate for further development in oncology.